Drug reference

Aclidinium bromide

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 282

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Maintenance treatment of chronic obstructive pulmonary Respiratory system disease ▶BY INHALATION OF POWDER ▶Adult: 375 micrograms twice daily DOSE EQUIVALENCE AND CONVERSION ▶Each 375 microgram inhalation of aclidinium bromide delivers 322 micrograms of aclidinium.

PDF page 282

Cautions

Arrhythmia (when newly diagnosed within last 3 months). heart failure (hospitalisation with moderate or severe heart failure within last 12 months). myocardial infarction within last 6 months. unstable angina

PDF page 282

Safety

Interactions

→Appendix 1: aclidinium

PDF page 282

Side Effects

▶Common or very common Diarrhoea. nasopharyngitis ▶Uncommon Angioedema ▶Rare or very rare Hypersensitivity

PDF page 282

Pregnancy

Manufacturer advises use only if potential beneﬁt outweighs risk.

PDF page 282

Breast Feeding

Manufacturer advises only use if potential beneﬁts outweigh risks.

PDF page 282

Dose and formulations

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Inhalation powder ▶Eklira (AstraZeneca UK Ltd) A Aclidinium bromide 375 microgram per 1 dose Eklira 322micrograms/dose Genuair | 60 dose P £32.50 DT = £32.50

PDF page 282

Clinical care

Patient And Carer Advice

Patients or carers should be given advice on appropriate inhaler technique.

PDF page 282

Dose text by age group

Adult

375 micrograms twice daily

First-line fragment. Read the complete Indications and Dose section above.

PDF page 282

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Aclidinium bromide

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 282

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

PDF page 282

Cautions

PDF page 282

Safety

Interactions

→Appendix 1: aclidinium

PDF page 282

Side Effects

▶Common or very common Diarrhoea. nasopharyngitis ▶Uncommon Angioedema ▶Rare or very rare Hypersensitivity

PDF page 282

Pregnancy

Manufacturer advises use only if potential beneﬁt outweighs risk.

PDF page 282

Breast Feeding

Manufacturer advises only use if potential beneﬁts outweigh risks.

PDF page 282

Dose and formulations

Medicinal Forms

PDF page 282

Clinical care

Patient And Carer Advice

Patients or carers should be given advice on appropriate inhaler technique.

PDF page 282

Dose text by age group

Adult

375 micrograms twice daily

First-line fragment. Read the complete Indications and Dose section above.

PDF page 282

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.